APA (7th ed.) Citation

Gatti, L., & Umansky, V. (2014). Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals. OncoTarget, 5(12), . https://doi.org/10.18632/oncotarget.2065

Chicago Style (17th ed.) Citation

Gatti, Laura, and Viktor Umansky. "Histone Deacetylase Inhibitor-temozolomide Co-treatment Inhibits Melanoma Growth Through Suppression of Chemokine (C-C Motif) Ligand 2-driven Signals." OncoTarget 5, no. 12 (2014). https://doi.org/10.18632/oncotarget.2065.

MLA (9th ed.) Citation

Gatti, Laura, and Viktor Umansky. "Histone Deacetylase Inhibitor-temozolomide Co-treatment Inhibits Melanoma Growth Through Suppression of Chemokine (C-C Motif) Ligand 2-driven Signals." OncoTarget, vol. 5, no. 12, 2014, https://doi.org/10.18632/oncotarget.2065.